Erythromycin: safety issues
Macrolide antimicrobials are widely used for the treatment of variety of community-acquired bacterial infections. This paper is aimed to review the data on the safety issues of erythromycin. The main attention is paid to the studies on erythromycin prokinetic properties, cardiotoxicity and fetotoxic...
Main Authors: | Matveev A.V., Krasheninnikov A.E., Egorova E.A. |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy
2018-08-01
|
Series: | Клиническая микробиология и антимикробная химиотерапия |
Subjects: | |
Online Access: | https://cmac-journal.ru/publication/2018/3/cmac-2018-t20-n3-p199/cmac-2018-t20-n3-p199.pdf |
Similar Items
-
Use of erythromycin for the treatment of severe chronic constipation in children
by: M.A. Bellomo-Brandão, et al.
Published: (2003-10-01) -
Thiopentone Induced Paralytic Ileus in Super Refractory Status Epilepticus: Erythromycin to the Rescue
by: Karen Ruby Lionel, et al.
Published: (2017-11-01) -
Erythromycin Resistance in Streptococcus pyogenes in Italy
by: Matteo Bassetti, et al.
Published: (2000-04-01) -
Look and Outlook on Enzyme-Mediated Macrolide Resistance
by: Tolou Golkar, et al.
Published: (2018-08-01) -
From Erythromycin to Azithromycin and New Potential Ribosome-Binding Antimicrobials
by: Dubravko Jelić, et al.
Published: (2016-09-01)